| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/2013 | EP2615918A1 Fatty acid synthase inhibitors |
| 07/24/2013 | EP2615916A1 Fused pyrazole derivatives as novel erk inhibitors |
| 07/24/2013 | EP2615915A1 Methods, compositions, and devices for managing chlorine dioxide release |
| 07/24/2013 | EP2615913A2 Sustained release pharmaceutical compositions comprising pregabalin |
| 07/24/2013 | EP2493462B1 Pterostilbene (pter) for use in the prevention and/or treatment of skin diseases, damages or injures |
| 07/24/2013 | EP2399579B9 Pharmaceutical dosage forms |
| 07/24/2013 | CN203075250U System for producing amino acid injection |
| 07/24/2013 | CN1989122B Novel cylopenta[b]benzofuran derivatives and the utilization thereof |
| 07/24/2013 | CN1984664B Methods for treating bleeding disorders using sulfated polysaccharides |
| 07/24/2013 | CN1980899B Quinazolinone derivatives as parp inhibitors |
| 07/24/2013 | CN1853730B Modified cytokines for use in cancer therapy |
| 07/24/2013 | CN1822845B Means for preventing and treating cellular death and their biological applications |
| 07/24/2013 | CN1795196B Use of amide in preparing compound agent for repairing corneal sensitivity |
| 07/24/2013 | CN1741797B Cyclic palladium compounds having coordinated thereto bis (diphenylphosphine) ferrocene ligands which inhibit the activity of proteins and enzymes |
| 07/24/2013 | CN1462191B Treatment of ocute coronary syndrome with GLP-1 |
| 07/24/2013 | CN103221542A Use of miRNAs for the diagnosis, prophylaxis, treatment and follow-p of diseases involving macroautophagy abnormalities |
| 07/24/2013 | CN103221415A Oxazolo [5, 4 -] pyridin-5-yl compounds and their use for the treatment of cancer |
| 07/24/2013 | CN103221412A (Aza)indolizine derivative and pharmaceutical use thereof |
| 07/24/2013 | CN103221411A A crystalline form of (R)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
| 07/24/2013 | CN103221410A Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 07/24/2013 | CN103221408A Triazine-oxadiazoles |
| 07/24/2013 | CN103221405A Substituted pyridine compound |
| 07/24/2013 | CN103221404A Nitrogen heterocyclic compounds useful as PDE10 inhibitors |
| 07/24/2013 | CN103221403A Heterocyclic compounds and their uses |
| 07/24/2013 | CN103221402A Triazole derivatives and their use for neurological disorders |
| 07/24/2013 | CN103221401A Process for preparing benzofuran derivatives substituted at position 5 |
| 07/24/2013 | CN103221399A 2-piperazin-1-l-4h-1,3-benzothiazin-4-one derivatives and their use for the treatment of mammalian infections |
| 07/24/2013 | CN103221396A Buguanide derivative compound |
| 07/24/2013 | CN103221392A Bridged spiro[2.4]heptane ester derivatives |
| 07/24/2013 | CN103221391A Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| 07/24/2013 | CN103221390A Glycine derivatives and their use as muscarinic receptor antagonists |
| 07/24/2013 | CN103221388A Novel sulfonamide compounds for inhibition of metastatic tumor growth |
| 07/24/2013 | CN103221386A Matrix metalloproteinase inhibitors |
| 07/24/2013 | CN103221383A Novel compound accelerating secretion of human-derived anti-microbial peptide, method for preparing same, and composition having same as active ingredient |
| 07/24/2013 | CN103221373A Methods and compositions for treating lung cancer |
| 07/24/2013 | CN103221094A Crystalline form of an inhibitor of MDM2/4 and P53 interaction |
| 07/24/2013 | CN103221060A Tumor growth controlling method targeting galactosylceramide expression factor-1 |
| 07/24/2013 | CN103221055A Modulation of TIMP1 and TIMP2 expression |
| 07/24/2013 | CN103221054A Novel polymer derivative of cytidine metabolism antagonist |
| 07/24/2013 | CN103221053A New treatments of hepatitis c virus infection |
| 07/24/2013 | CN103221052A Fulvestrant compositions and methods of use |
| 07/24/2013 | CN103221051A IBAT inhibitors for treatment of metabolic disorders and related conditions |
| 07/24/2013 | CN103221050A Combination of bevacizumab and 2,2-dimethyl-N-((S)-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-N'-(2,2,3,3,3-pentafluoro-propyl)-malonamide for the treatment of proliferative disorders |
| 07/24/2013 | CN103221049A Aprepitant l-proline composition and cocrystal |
| 07/24/2013 | CN103221048A Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof |
| 07/24/2013 | CN103221047A Compounds and methods |
| 07/24/2013 | CN103221046A Piperidinyl-substituted lactams as gpr119 modulators |
| 07/24/2013 | CN103221045A Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions |
| 07/24/2013 | CN103221044A Xanthanodien for the treatment of cancer |
| 07/24/2013 | CN103221043A Inhibitors of ERK for developmental disorders of neuronal connectivity |
| 07/24/2013 | CN103221042A Methods of treating bladder cancer |
| 07/24/2013 | CN103221041A Therapeutic or prophylactic agent for corneal epithelium disorders and/or conjunctival epithelium disorders |
| 07/24/2013 | CN103221040A Disulfiram formulation and uses thereof |
| 07/24/2013 | CN103221039A Airway administration of angiogenesis inhibitors |
| 07/24/2013 | CN103221037A Novel pharmaceutical compositions |
| 07/24/2013 | CN103221035A C-MET modulator pharmaceutical compositions |
| 07/24/2013 | CN103221032A Pharmaceutical composition |
| 07/24/2013 | CN103220910A Methods of use of cyclic amide derivatives to treat schizophrenia |
| 07/24/2013 | CN103215336A Preparation method of betulinic acid 28-O-beta-D-glucopyranoside and use of betulinic acid 28-O-beta-D-glucopyranoside |
| 07/24/2013 | CN103215207A Pseudomonas strain applicable to oil accumulation environment and application thereof |
| 07/24/2013 | CN103214635A pH sensitive super-hydrophobic triblock copolymer as well as preparation method and application thereof |
| 07/24/2013 | CN103214591A 2,5-anhydrated talose or derivatives thereof terminal low-molecular-weight glycosaminoglycan derivative |
| 07/24/2013 | CN103214547A Compound and an application in preparation of antibiosis medicament |
| 07/24/2013 | CN103214543A New maslinic acid derivatives, preparation method, and applications of new maslinic acid derivative in antitumor drug |
| 07/24/2013 | CN103214542A B-nor-6-(4'-alkyl) aminothizone cholestane compound, and preparation method and application thereof in anticancer drugs |
| 07/24/2013 | CN103214536A Polyhydroxy steroidal compounds separated from coral, and application thereof |
| 07/24/2013 | CN103214497A Physalin A extracting process and medical application thereof |
| 07/24/2013 | CN103214489A Multi-target kinase inhibitors with antitumor activities, and preparation method thereof |
| 07/24/2013 | CN103214488A Quinolinone derivative, pharmaceutical composition by taking quinolinone derivative as active component and preparation method |
| 07/24/2013 | CN103214486A Beta-carboline derivative or medicinal salt as well as preparation method and anti-tumour application thereof |
| 07/24/2013 | CN103214484A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214483A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214482A Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors |
| 07/24/2013 | CN103214481A Novel imidazo[1,2-a]pyridines compound, preparation method, pharmaceutical composition containing imidazo[1,2-a]pyridines compound and application |
| 07/24/2013 | CN103214480A Pyrazolopyridines alkynylbenzene compound and medicinal composition and application |
| 07/24/2013 | CN103214479A Pyrazole naphthylurea tyrosine kinase inhibitor and its application |
| 07/24/2013 | CN103214478A Pyridineoxopyridazine derivatives |
| 07/24/2013 | CN103214472A Preparation of two novel non-ATP (Adenosine Triphosphate) competitive FGFR1 (Fibroblast Growth Factor Receptor1) inhibitors and anti-tumor activity of two novel non-ATP competitive FGFR1 inhibitors |
| 07/24/2013 | CN103214471A Novel compound |
| 07/24/2013 | CN103214470A Novel anticancer compound synthesized by reaction of ketone and indole derivative |
| 07/24/2013 | CN103214468A Hairpin polyamide modified by chiral (S)-beta-hydroxyl-gamma-amino acid and application for same |
| 07/24/2013 | CN103214467A 5-[[4-[(2, 3-dimethyl-2H-indazole-6-yl) methylamino]-2-pyrimidyl] amino]-2-methyl-benzsulfamide derivative and preparation method and applications thereof |
| 07/24/2013 | CN103214464A Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 07/24/2013 | CN103214459A Pantoprazole sodium crystalline compound, pharmaceutical composition and preparation method thereof |
| 07/24/2013 | CN103214456A Benzimidazole compound with antitumour activity as well as preparation method and application thereof |
| 07/24/2013 | CN103214454A Bilastine crystal and preparation method thereof |
| 07/24/2013 | CN103214451A Bicyclol amino-acid ester as well as preparation method and application for same |
| 07/24/2013 | CN103214450A Modulators of atp-binding cassette transporters |
| 07/24/2013 | CN103214447A Liparis nervosa extract monomeric compound as well as preparation method and application thereof |
| 07/24/2013 | CN103214445A Preparation method and use of quercetin amide derivative |
| 07/24/2013 | CN103214444A Flavone sulphonamide derivative with anti-cancer activity as well as preparation method and application thereof |
| 07/24/2013 | CN103214441A Resveratrol dimer derivative as well as preparation and application method thereof |
| 07/24/2013 | CN103214431A 2,3-dihydrobenzazapine*compound or its salt and its medical application |
| 07/24/2013 | CN103214429A 1-substituted phenyl-3-(N-phenothiazinyl)propyl-2-ene-1-ketone as well as preparation method and application thereof |
| 07/24/2013 | CN103214427A Crystal form and application of R-pramipexole |
| 07/24/2013 | CN103214422A Preparation methods and anti-cancer effect of novel substituted amido imidazolone derivatives |
| 07/24/2013 | CN103214409A Synthesis of tetracyclines and analogues thereof |
| 07/24/2013 | CN103214382A Meclofenoxate hydrochloride compound and pharmaceutical composition thereof |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN103214370A 1, 6-O-dicaffeoyl sorbitol ester as well as derivative thereof and application |